黑料网

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

A clinical trial on optimization of the heparin utilization in coronary angiography

3rd International Conference on Clinical Pharmacy

Hanaa Alghonimy

Ain Shams University, Egypt

ScientificTracks Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Unfractionated Heparin (UFH) has been conventionally used during Coronary Angiography (CAG). However, no data is available for the dosage required. Vascular complications are still frequent in special group of patients. The objective of this study was to determine the incidence of bleeding, vascular, and ischemic complications using three different heparin regimens after successful coronary angiography. This study enrolled 105 patients divided into three groups: Group 1: (n=35 patients) receiving a dose of 5000 IU (systemic heparinization), Group 2: (n=35 patients) receiving a dose of 5000 IU of heparin on the flush saline and Group 3: (n=35 patients) control group will receive flush saline, i.e., normal saline flush. All patients included in the study will be subjected to full history taking, complete general and local examination of the heart and blood vessels, 12 leads resting ECG, Routine laboratory investigations including fasting blood sugar, liver and kidney function tests, complete blood picture, lipid profile and coagulation profile. Descriptive statistics was done including mean, standard deviation and percentage. Comparison between groups was done using one way analysis of variance and comparison between the parametric variables was done using chi-square test. Results of the current study showed that there was no significant difference between the three groups regarding the number of diseased vessels or the incidence of slow coronary flow or incidence of normal coronary arteries (p>0.05). The clotting time and PTT were not significantly different in the three groups before coronary angiography (p>0.05). After coronary angiography, clotting time and PTT were significantly higher among group I and II than that of group III (p<0.05). Comparison between before and after coronary angiography in group I and II, the results showed that the clotting time and PTT increased significantly after the procedure (p<0.05) while, in group III there were no significant difference between before and after the procedure (p>0.05). The sheath removal duration was significantly higher among group I and group II than that of group III (p<0.05). There were no major complications recorded in any of the patients in the three groups. Routine elective coronary angiography may be performed without the use of UFH was found to be safe. However, further detail study is recommended.
Biography

Email: hana102moh@hotmail.com

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top